AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 14, 2026

Bionexus Gene Lab Corp BGLC Stock Forecast

AI-powered price prediction and analysis for Bionexus Gene Lab Corp · Total · absolute moveSwitch to Alpha

Follow
AI 90-Day Forecast ▼ Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence n/a Spearman Correlation

See BGLC's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

BGLC
Fundamentals

Key Statistics

EPS$-0.16
ROE-27.7%
Net Margin-44.0%
Current Ratio6.08x
D/E Ratio0.12x
Company

About Bionexus Gene Lab Corp

Bionexus Gene Lab Corp (BGLC) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry.

Industrial Applications and Services Services-Medical Laboratories Nasdaq
News

Latest News

  • Loading...

Where BGLC sits on the market map

Industrial Applications and Services · Services-Medical Laboratories
Explore the map →
Industry Peers

Services-Medical Laboratories Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
BGLC Bionexus Gene Lab Corp ▼ N/A –
NTRA Natera, Inc. ▶ $57.03B –
DGX Quest Diagnostics Inc ▼ $25.44B 24.0x
LH Labcorp Holdings Inc. ▼ $25.44B 25.4x
GH Guardant Health, Inc. ▲ $21.75B –
CAI Caris Life Sciences, Inc. ▲ $8.35B –
GRAL Grail, Inc. ▲ $6.27B –
RDNT Radnet, Inc. ▶ $5.63B –
BLLN Billiontoone, Inc. ▲ $4.46B –
VCYT Veracyte, Inc. ▲ $3.47B 30.3x
CDNA Caredx, Inc. ▲ $3.38B 30.5x
CELC Celcuity Inc. ▶ $3.09B –
FTRE Fortrea Holdings Inc. ▲ $1.99B –
PSNL Personalis, Inc. ▲ $1.69B –
LMRI Lumexa Imaging Holdings, Inc. ▲ $1.02B –
CSTL Castle Biosciences Inc ▲ $1.00B –
FLGT Fulgent Genetics, Inc. ▲ $579M –
BDSX Biodesix Inc ▲ $264M –
XGN Exagen Inc. ▲ $205M –
SERA Sera Prognostics, Inc. ▶ $82M –
CFOR Capforce Inc. ▲ $47M –
AMS American Shared Hospital Services ▲ $8M –
ADVB Advanced Biomed Inc. ▼ $6M –
LUDG Ludwig Enterprises, Inc. ▼ $840K –
FCHS First Choice Healthcare Solutions, … ▼ $300K –
ACON Aclarion, Inc. ▶ N/A –
BNR Burning Rock Biotech Ltd ▲ N/A –
FRNM Freenome, Inc. ▼ N/A –
MDXH Mdxhealth Sa ▶ N/A –
RNLXY Renalytix Plc ▼ N/A –
FAQ

FAQ

Is Bionexus Gene Lab Corp a good stock to buy?

Our AI analyzes Bionexus Gene Lab Corp daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Bionexus Gene Lab Corp predictions?

A per-ticker accuracy statistic for BGLC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Bionexus Gene Lab Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Bionexus Gene Lab Corp? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.